|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 |
| (11) | Number of the document | 2408816 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10708688.6 |
| Date of filing the European patent application | 2010-03-16 | |
| (97) | Date of publication of the European application | 2012-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/027422 |
| Date | 2010-03-16 |
| (87) | Number | WO 2010/107752 |
| Date | 2010-09-23 |
| (30) | Number | Date | Country code |
| 162154 P | 2009-03-20 | US | |
| 306829 P | 2010-02-22 | US |
| (72) |
HSU, Hailing, US
FOLTZ, Ian, CA
ARORA, Taruna, US
JACOBSEN, Frederick, W., US
|
| (73) |
Amgen Inc.,
Law Department One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (54) | ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY |
| ALPHA-4-BETA-7 HETERODIMER SPECIFIC ANTAGONIST ANTIBODY |